Metraipolis › archive › dc_88bac4e439d1

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT) — Europe PMC PMID:36174069

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36174069
DOI
10.1371/journal.pone.0271304
License (as archived)
CC0-1.0
Archived
2026-10-08T06:31:06.239Z
SHA-256 of the archived text
6a7a59180709d2f17ddad32c659ce81e455f302ca0031a37c30357e6c44bc244
Stable URL of this page
https://metraipolis.com/documento/dc_88bac4e439d1

How to cite

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT) — Europe PMC PMID:36174069 — Europe PMC (en), https://europepmc.org/article/MED/36174069 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_88bac4e439d1 (Metraipolis archive dc_88bac4e439d1, sha256 6a7a59180709d2f17ddad32c659ce81e455f302ca0031a37c30357e6c44bc244)
BibTeX
@misc{dc88bac4e439d1,
  title = {A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT) — Europe PMC PMID:36174069},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36174069},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_88bac4e439d1; sha256 6a7a59180709d2f17ddad32c659ce81e455f302ca0031a37c30357e6c44bc244},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36174069. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background and aims: We hypothesized that a drug's clinical signature (or phenotype) of liver injury can be assessed and used to quantitatively develop a computer-assisted DILI causality assessment-tool (DILI-CAT). Therefore, we evaluated drug-specific DILI-phenotypes for amoxicillin-clavulanate (AMX/CLA), cefazolin, cyproterone, and Polygonum multiflorum using data from published case series, to develop DILI-CAT scores for each drug. Methods: Drug specific phenotypes were made up of the following three clinical features: (1) latency, (2) R-value, and (3) AST/ALT ratio. A point allocation system was developed with points allocated depending on the variance from the norm (or "core") for the 3 variables in published datasets. Results: The four drugs had significantly different phenotypes based on latency, R-value, and AST/ALT ratio. The median cyproterone latency was 150 days versus < 43 days for the other three drugs (median: 26 for AMX/CLA, 20 for cefazolin, and 20 for Polygonum multiflorum; p<0.001). The R-value for the four drugs was also significantly different among drugs (cyproterone [median 12.4] and Polygonum multiflorum [median 10.9]) from AMX/CLA [median 1.44] and cefazolin [median 1.57; p<0.001]). DILI-CAT scores effectively separated cyproterone and Polygonum multiflorum from AMX/CLA and cefazolin, respectively (p<0.001). As expected, because of phenotypic overlap, AMX/CLA and cefazolin could not be well differentiated. Conclusions: DILI-CAT is a data-driven, diagnostic tool built to define drug-specific phenotypes for DILI adjudication. The data provide proof of principle that a drug-specific, data-driven causality assessment tool can be developed for different drugs and raise the possibility that such a process could enhance causality assessment methods.

Tema degli esploratori: matematica e informatica teorica (ricerca Europe PMC «probability theory», solo open access).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-09-29).
Identificativi: PMID 36174069 · PMCID PMC9521919 · DOI 10.1371/journal.pone.0271304.
Descrittori MeSH principali: Chemical and Drug Induced Liver Injury.
Pagina: https://europepmc.org/article/MED/36174069 — https://doi.org/10.1371/journal.pone.0271304. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-08T05:56:17.240Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.